Package 58411-657-10

Brand: shiseido future solution lx infinite treatment primer

Generic: titanium dioxide, octinoxate, and ensulizole
NDC Package

Package Facts

Identity

Package NDC 58411-657-10
Digits Only 5841165710
Product NDC 58411-657
Product ID 58411-657_47b9be75-c9c2-b19a-e063-6294a90a3412
Description

1 TUBE in 1 CARTON (58411-657-10) / 40 mL in 1 TUBE

Marketing

Marketing Status
Marketed Since 2021-05-01
Brand shiseido future solution lx infinite treatment primer
Generic titanium dioxide, octinoxate, and ensulizole
Sample Package No

Linked Drug Pages (1)

SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "47b9be75-c9c2-b19a-e063-6294a90a3412", "openfda": {"unii": ["9YQ9DI1W42", "4Y5P7MUD51", "15FIX9V2JP"], "spl_set_id": ["ff088b0c-27c9-4ea8-bf94-6261378c7190"], "manufacturer_name": ["SHISEIDO AMERICAS CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (58411-657-10)  / 40 mL in 1 TUBE", "package_ndc": "58411-657-10", "marketing_start_date": "20210501"}], "brand_name": "SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER", "product_id": "58411-657_47b9be75-c9c2-b19a-e063-6294a90a3412", "dosage_form": "EMULSION", "product_ndc": "58411-657", "generic_name": "TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE", "labeler_name": "SHISEIDO AMERICAS CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER", "active_ingredients": [{"name": "ENSULIZOLE", "strength": ".428 g/40mL"}, {"name": "OCTINOXATE", "strength": "1.71 g/40mL"}, {"name": "TITANIUM DIOXIDE", "strength": "1.77 g/40mL"}], "application_number": "M020", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210501", "listing_expiration_date": "20271231"}